A new zebrafish model to study balance issues in progressive supranuclear palsy
Official title: A Phenotype-Optimized Zebrafish Model of Progressive Supranuclear Palsy
Funded at New York University School of Medicine · NIH-10764950 · Data updated 2026-11-12
This study is exploring a new way to understand progressive supranuclear palsy (PSP) by using zebrafish to mimic the brain changes that happen in this condition, which could help researchers find better treatments for people with PSP.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 15, 2022 |
| Project end | December 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $188,955 |
| NIH project number | 5R33NS125280-03 |
| Project ID | NIH-10764950 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with progressive supranuclear palsy who experience significant balance issues.
✕Less likely to help
Patients with other neurodegenerative diseases that do not involve Tau pathology may not benefit from this research.
What this research studies
This research investigates progressive supranuclear palsy (PSP), a neurodegenerative disease that causes severe balance problems and other neurological symptoms. The team is developing a zebrafish model that mimics the Tau protein pathology associated with PSP, allowing for better understanding and evaluation of potential treatments. By using zebrafish, which are small and have easily observable behaviors, researchers aim to link the underlying biological mechanisms of balance deficits to the symptoms experienced by patients. The model will be validated through various neurological and behavioral tests to ensure its relevance to human PSP.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve balance and reduce falls in patients with progressive supranuclear palsy.
How similar studies have gone: Previous research has shown promise in using animal models to study neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Schoppik, David — New York University School of Medicine
- Study coordinator: Schoppik, David
Related research
Other NIH-funded projects on the same topics.
-
Imaging brain changes over time in progressive supranuclear palsy
This project uses repeated brain scans to track disease-related changes over time in people with progressive supranuclear palsy.
-
Tau’s effect on protein production in Alzheimer’s and PSP
This grant investigates how abnormal tau protein disrupts the way cells make proteins, which may contribute to memory problems in Alzheimer’s disease and PSP.
-
Platform to try new treatments for progressive supranuclear palsy
This project will compare three medicines for people with mild to moderate progressive supranuclear palsy to learn if they are safe and help symptoms.
-
Investigating tau protein accumulation and its effects on movement in brain injuries.
This study is looking at how repeated head injuries might lead to movement problems, like those seen in Parkinson's disease, by examining changes in the brain after someone has passed away, and it aims to find clues that could help diagnose these issues better for people affected by chronic traumatic encephalopathy (CT
-
Using brain stimulation to improve balance in patients with progressive supranuclear palsy
This study is looking at a safe and painless way to use brain stimulation to help people with progressive supranuclear palsy (PSP) improve their balance and reduce the risk of falling, so they can stay active and independent for longer.
-
Understanding walking and balance problems in a rare neurological condition.
This study is looking at how walking and balance problems affect people with progressive supranuclear palsy (PSP) and aims to create better ways to measure these issues so that patients can receive improved care and support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.